
Cracking the biotech market through smart investment
A lot has happened to Zura Bio, the UK clinical-stage biotechnology company, in a short time. In March, it became the first UK listing on the Nasdaq in 2023 following a $65m business combination with a special purpose acquisition company (SPAC). After the …